Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

36

Revenue 2017

Xtandi

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Xtandi was produced by Astellas.

Reference price bill tabled in US House and Senate

Reference price bill tabled in US House and Senate savings for several other drugs including Pfizer’s hormone replacement therapy Premarin (conjugated oestrogens),   Merck &Co’s Januvia (sitagliptin) for diabetes, and Astellas/Pfizer’s prostate cancer therapy Xtandi (enzalutamide).

Bayer preps filings for new prostate cancer drug

Bayer preps filings for new prostate cancer drug If approved, will challenge Xtandi and Erleada. Armed with new phase 3 data, Bayer has said it intends to press ahead with regulatory filings for its anti-androgen drug darolutamide in ... Moreover, it also seems to retain activity against most androgen

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use

Daily Brief: Limited NICE recommendation for Fasenra, Urovant takes aim at an IPO, Xtandi expands use FDA approves broader use of Xtandi. Pfizer and Astellas have gained US approval for broader use of their prostate cancer treatment Xtandi. ... The approval makes Xtandi the first and only oral medication FDA-approved for both non-metastatic and

Daily Brief

Daily Brief As an example, the algorithm recommends a price of $3, 094 for each course of Pfizer’s prostate cancer drug Xtandi – much lower than the current UK list price (almost 12

EMA starts review of Xtandi in non-metastatic prostate cancer

EMA starts review of Xtandi in non-metastatic prostate cancer So, if approved the new indication would move Xtandi up the treatment chain and could allow it to be used in more patients. ... Erleada is the first to claim approval, but Xtandi benefits from longstanding familiarity in CRPC treatment.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Measures for measures
Why pharma’s marketing metrics must close the loop...
Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...

Infographics